Kim-Schulze Seunghee, Taback Bret, Kaufman Howard L
The Tumor Immunology Laboratory, Division of Surgical Oncology, 622 West 168th Street, Columbia University, New York, NY 10032, USA.
Surg Oncol Clin N Am. 2007 Oct;16(4):793-818, viii. doi: 10.1016/j.soc.2007.07.011.
This review provides a review of the basic biology of the major cytokines under consideration for use in tumor immunotherapy. The authors also describe the clinical role of cytokine therapy for human tumors, with a focus on melanoma and renal cell carcinoma. Finally, they present details of new cytokines and suggest possible direction for future clinical investigation using new cytokines or combinations of biologic agents. A better understanding of cytokine biology, coupled with new insights into the role of immunoregulation and the microenvironment in patients who have cancer, has provided new therapeutic targets for the treatment of human cancer.
本综述对正在考虑用于肿瘤免疫治疗的主要细胞因子的基础生物学进行了回顾。作者还描述了细胞因子疗法在人类肿瘤中的临床作用,重点关注黑色素瘤和肾细胞癌。最后,他们介绍了新细胞因子的详细信息,并提出了使用新细胞因子或生物制剂组合进行未来临床研究的可能方向。对细胞因子生物学的更好理解,以及对免疫调节和微环境在癌症患者中的作用的新见解,为人类癌症的治疗提供了新的治疗靶点。